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DOI 10.1016/j.chembiol.2007.07.005The viability of a woman’s eggs
declines in her mid 30s and drops pre-
cipitously in her 40s. A healthy older
woman can still carry a pregnancy suc-
cessfully if she uses eggs from a youn-
ger donor. What if she could freeze her
own eggs? After all, IVF, or in vitro fer-
tilization, so radical when introduced
in the mid 80s, is now commonplace.
According to Fertile Hope (http://www.
fertilehope.org), an organization that
promotes fertility research for cancer
patients, 139 fertility clinics in the U.S.
and two companies are now entering
the frozen egg business.
Egg freezing could be a godsend for
women who are facing cancer treat-under 35 and obtained a pregnancy
rate of over 40 percent. Treatments
cost U.S. $4000 a cycle and $2400
for cancer patients.
Banking on Liquid Nitrogen
Instead of Luck
While C. Chen published a paper in the
Lancet in 1986 detailing a pregnancy
from frozen eggs less than 8 years
after the first IVF pregnancy, egg freez-
ing was kick-started by an Italian law
that restricted the number of eggs
that can be fertilized and embryos
implanted in IVF procedures as well
as forbade the freezing of embryos.
Elenora Porcu, M.D., and RaffaelaBut a bigger market lurks: healthy women who delay child-
bearing or worry that they won’t meet the right partner in
time and are seeking a bit of insurance to safeguard their
fertilityments or other medical procedures
that could impair fertility, have family
members experiencing early meno-
pause, or object to discarding left
over embryos after IVF because of per-
sonal or religious reasons. But a bigger
market lurks: healthy women who de-
lay childbearing or worry that they
won’t meet the right partner in time
and are seeking a bit of insurance to
safeguard their fertility.
‘‘Our studies show that egg freezing
allows pregnancy rates comparable to
fresh eggs,’’ says Dr. Seang Lin Tan,
director of the McGill Reproductive
Centre. Tan’s team has developed
a procedure called IVM, or in vitro
maturation, which involves extracting
immature eggs without using fertility
drugs, maturing them in a dish, and
vitrifying them in a protective device
called a Cryoleaf. So far, Tan’s team
has tried this procedure in two studies
that included a total of 36 womenFabbri, B.Sc., both at the University
of Bologna, began experimenting
with freezing eggs. Other groups got
interested as well, but early rates of
live births were dismal.
Slow-rate freezing and vitrification,
the two main egg preservation tech-
niques, originated 20 years ago.
Methods improved in the mid 90s not
only because of more nuanced use
of cryoprotectants, but also because
of the use of ICSI (intra cytoplasmic
sperm injection) to insert sperm di-
rectly through the egg’s envelope,
which loses permeability in freezing.
Currently, most labs slow-freeze
eggs immersed in a sodium chloride-
containing media, with 1,2 propane-
diol and sucrose. Some labs use a so-
dium-depleted media by substituting
choline chloride for sodium chloride.
In vitrification, eggs are exposed to
high concentrations of toxic cryo-
protectants for short periods, thenChemistry & Biology 14, July 2007 ªabruptly supercooled in liquid nitro-
gen. Due to their size, eggs have a
relatively low surface to volume ratio.
Thus, the high cooling rate that is
necessary to vitrify water is harder to
achieve. Ice crystals can form in the
thawing process as well.
Overcoming the Humpty
Dumpty Syndrome
Anywhere from 200 to 400 babies have
been born from frozen eggs so far. [1]
Sperm and embryos are routinely fro-
zen, producing hundreds of thousands
of births in the last few decades, but
unfertilized eggs don’t like the cold.
‘‘A cleaved embryo is not the same
volume; it is subdivided’’ says Thomas
‘‘Rusty’’ Pool, scientific director of the
Fertility Center of San Antonio. As an
unfertilized egg is a large cell with
a high water content, freezing can
damage its cytostructure, causing
its meiotic spindle, which holds the
DNA, to disassemble. If it doesn’t
properly reassemble in thawing, the
chromosomes can get scrambled.
Freezing also affects the permeability
of the egg’s shell. Could freezing lead
to birth defects? ‘‘We have no way of
judging a good egg yet.’’ Pool said.
‘‘The long term safety and efficacy
are not known.’’
ViaCell Branches into Egg
Banking and Media
In July, the FDA approved Boston-
based ViaCell (http://www.viacellinc.
com) to commence a clinical trial eval-
uating the safety of ViaCyte, a choline
chloride-based cryoprotectant media.
The product is based on the work of
Jacques Cohen, Ph.D., scientific di-
rector at the Institute for Reproductive
Medicine and Science at St. Barnabas
in New Jersey. The trial will enroll 300
healthy women between 21 and 35
years of age in the United States
and other countries, whose husbands
suffer from male factor infertility.2007 Elsevier Ltd All rights reserved 729
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services. The primary efficacy end-
point is 50 live births.
ViaCell, a public 270 employee com-
pany, was incorporated in 1994 and is
capitalized at $50 million with no debt.
According to Marc Beer, president and
CEO, ViaCell had $54 million in sales
last year from its cord banking business
and is conducting research in the areas
of cancer, cardiac disease, and diabe-
tes. The company also collaborates
with Amgen on cancer therapies.
Getting into the egg freezing busi-
ness is a strategic move for a company
that markets umbilical cord blood
banking to anxious parents-to-be, as
it relies heavily both on its expertise
in cell preservation as well as a market-
ing network that focuses on consumer
education, sending cord blood bro-
chures to hospital waiting rooms and
advertising in pregnancy magazines.
‘‘The vast majority [of clients] don’t
have a history of diseases,’’ said
Beer. ‘‘They are really buying it to be
an insurance policy.’’ According to
Beer, the company’s cord blood busi-
ness has an 81% gross profit margin.
‘‘If you want to volunteer for this [egg
freezing], you are taking a huge risk,’’
said Jacques Cohen. ‘‘You only have
eggs from one cohort. Even from the
best clinic,.you better do this three
times. The risk is like any medical pro-
cedure. They [ViaCell] are pioneers.
They may be 5–10 years too early.
From a patient point of view, I’d talk
her out of it. I’m biased, because I
need this technology to work. Once
the trial results are in, I may change
my mind.’’
Extending Fertility Insurance
Another enterprising company is Bos-
ton-based Extend Fertility (http://
www.extendfertility.com), started by
entrepreneur Christy Jones 3 years
ago. The company partners with a net-
work of six fertility centers with 20 lo-
cations to offer egg freezing services.
Extend uses a slow freezing protocol.
About 70% of their 200 clients have
frozen their eggs because of delaying
childbearing. The remainder are can-
cer patients or face conditions that
could impair their fertility.
According to Charlotte Frank Sage,
director of clinical affairs and opera-730 Chemistry & Biology 14, July 2007 ªtions, similar technology resulted in
over 70 births at the Porcu lab in Bolo-
gna. Extend recommends that its
clients freeze about 20 eggs for best
results. About a third of their clients
have opted for multiple rounds. The
company’s client cutoff age is 40, but
if a younger woman’s FSH (follicle
stimulating hormone) levels and antral
follicle counts, which indicate egg
reserve, exceed normal boundaries,
they will decline her. Extend’s success
depends on heavy consumer educa-
tion, as younger women who would
get the best results may not necessar-
ily feel any urgency to freeze their
eggs.
Dr. Alan Copperman, Extend’s med-
ical director, says he was convinced to
join the program by a study of four
women using donor eggs, three of
whom became pregnant and gave
birth. Extend Fertility claims nine births
in their satellite centers using their
technology in various studies, but, so
far, none of their clients have thawed
their eggs to attempt pregnancy [2].
Freezing eggs with Extend costs
between US $10,000 and $13,000
per cycle, plus the cost of fertility med-
ications, which can range from $2,000
to $5,000—a total of $12,000–$18,000
per cycle. Extend’s storage fees are
$440 per year.
Sorting the Numbers
In 2006, Dr. Kutluk Oktay and col-
leagues at the New York Presbyterian
Hospital – Weill Medical College of
Cornell University published a meta-
analysis of egg freezing data aggre-
gated from various centers. Between
2002 and 2004, for 476 slow-frozen
thawed eggs, the fertilization rate was
between 60% and 65%, but only
about 5% of total frozen eggs resulted
in live births. Dr. Oktay then looked at
the figure per transfer (only viable em-
bryos were transferred) and calculated
a rate close to 38% of clinical pregnan-
cies and 32% of live births; therefore, it
took approximately 20 eggs to get one
baby. This is half the rate of success of
an IVF cycle, which at best averages
about 60% chance of pregnancy per
cycle. In the last few years, a number
of groups around the world are report-
ing higher rates of fertilization and live2007 Elsevier Ltd All rights reservedbirths after freezing, but much of that
data remains unpublished.
‘‘Our data suggest that the live birth
rate is better than 4% per frozen egg,
probably more like 5% or 6%,’’ said
Richard Paulson, medical director,
USC Fertility. ‘‘But even if you accept
the average of the reported series as
being 4% per frozen egg, that still
adds up to about 50% aggregate
probability of a baby from one batch
of frozen eggs (our series had 55%).
With these numbers, I don’t think that
it is reasonable any longer to deny
access to this technology to well-
informed individuals who wish to pre-
serve their eggs for the purpose of
future fertility.’’
An ongoing randomized trial com-
paring slow freezing with vitrification
is being conducted by Gary Smith,
Ph.D., director of the Assisted Repro-
ductive Technologies Laboratory at
the University of Michigan, with col-
leagues in Brazil. As of April, 170 pa-
tients (average age 32) engaging in
IVF cycles are freezing any eggs over
ten retrieved. The endpoint is 40 preg-
nancies, but there is not enough data
yet. ‘‘Right now we take 21 oocytes
per pregnancy for vitrification and 45
to achieve a pregnancy for slow rate
freezing.’’ Smith said.
‘‘You have to look at the denomina-
tor,’’ says Dr. Glenn Schattman, asso-
ciate professor of Obstetrics and
Gynecology at the New York Presbyte-
rian Hospital – Weill Medical College of
Cornell University. ‘‘How many eggs
do they need to freeze and thaw, and
how many have they transferred back
to people? .There is not verifiable
auditable data. I think that women
need to be told. I think that ASRM’s
[American Society for Reproductive
Medicine] policy, it is the bottom line
[that] it is still research. They should
not base their childbearing or future
family on it.’’
Fertility insurance is a fine concept,
but since there is little published,
peer-reviewed data, a woman paying
per cycle should know the live birth
rate per egg extraction cycle at her
chosen clinic. The only guarantee in
the world of assisted reproduction is
that peace of mind does not come
cheaply. The number of eggs neces-
sary to get a baby will also vary due
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the bank that success rates will even-
tually get better, but in the meantime,
to improve her odds, she could simply
fertilize her extracted eggs with donor
sperm and freeze the embryos.REFERENCES
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